Recap: Fusion Pharmaceuticals Q1 Earnings

Fusion Pharmaceuticals FUSN reported its Q1 earnings results on Thursday, May 11, 2023 at 07:15 AM.

Here's what investors need to know about the announcement.

Earnings

Fusion Pharmaceuticals missed estimated earnings by 40.62%, reporting an EPS of $-0.45 versus an estimate of $-0.32.

Revenue was down $557 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 0.48% increase in the share price the next day.

Here's a look at Fusion Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.56 -0.50 -0.53 -0.48
EPS Actual -0.55 -0.55 -0.44 -0.46
Revenue Estimate 20K 100K 140K 1.12M
Revenue Actual 140K 166K 570K 585K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Fusion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!